FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
05-02-2017, 05:43 AM | #1 | |||
|
||||
Grand Magnate
|
Brainstorm Cell Therapeutics Set To Begin Phase 3 In Amyotrophic Lateral Sclerosis
Brainstorm Cell Therapeutics Set To Begin Phase 3 In Amyotrophic Lateral Sclerosis - BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) | Seeking Alpha |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
New Treatment for Amyotrophic Lateral Sclerosis Passes Phase III Trials | ALS News & Research | |||
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Is Running Up On ALS Win | ALS News & Research | |||
Cognition and Amyotrophic Lateral Sclerosis (ALS) | ALS News & Research | |||
BrainStorm Cell Therapeutics Inc. (BCLI) previously at $0.77 up 19% at $0.92 with 370 | ALS News & Research | |||
Stem cell treatment in Amyotrophic Lateral Sclerosis. | ALS News & Research |